The Pharmaceutical Journal | Artificial Intelligence: will it change the way drugs are discovered?

As of January 1st, 2025, the Swiss Data Science Center embraces its new role as a National Research Infrastructure.

Dear SDSC Community, we are excited to introduce SDSC News, a platform to keep you informed about the latest developments, projects,...

Press Release: The Swiss Data Science Center Establishes a Permanent Presence at Biopôle with Support from the Canton of Vaud.

Artificial Intelligence (AI) is not an alien word anymore nowadays. We see both academic and industrial institutions adopting AI topics as a part of their curriculum and use cases to accelerate existing processes. The pharmaceutical industry is one of them.

Ensuring compliance with privacy regulations can be a challenging task, requiring continuous monitoring and the ongoing collection of consent for data usage. The Swiss Data Custodian is an open-source framework that provides the necessary tools to govern data access and processing and enables secure and compliant data usage through contractual agreements.

Researchers at Eawag and the Swiss Data Science Center have trained AI algorithms with a comprehensive ecotoxicological dataset. Now their machine learning models can predict how toxic chemicals are to fish.